Dabing Chen is a Principal Scientist in pharmaceutical sciences at Biogen, specializing in biopharmaceutics, solid state, and preformulation. They previously served as a Senior Principal Scientist at Boehringer Ingelheim, leading API crystallization and isolation projects from 2015 to 2022. Dabing has extensive experience in formulation development for toxicology studies, project management, and biopharmaceutical assessment, having also worked as a Principal Research Investigator at Arvinas from 2022 to 2025. Currently, they are pursuing a Doctor of Philosophy in Pharmaceutics at the University of Minnesota, alongside a Bachelor of Science and Master of Science in Pharmacy and Pharmaceutics, respectively, at Peking University Health Science Center.
This person is not in the org chart
This person is not in any teams
This person is not in any offices